0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Azacitidine Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-12E10557
Home | Market Reports | Health| Pharmacy
Global and United States Azacitidine Drug Market Report Forecast 2022 2028
BUY CHAPTERS

Global Azacitidine Drug Market Research Report 2025

Code: QYRE-Auto-12E10557
Report
September 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Azacitidine Drug Market Size

The global market for Azacitidine Drug was valued at US$ 94.8 million in the year 2024 and is projected to reach a revised size of US$ 119 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Azacitidine Drug Market

Azacitidine Drug Market

Azacitidine is used to treat myelodysplastic syndromes (MDS), a number of disorders in which not enough healthy blood cells are produced in the bone marrow, leaving patients with low blood counts. In healthy bone marrow, stem cells become red blood cells, white blood cells or platelets. In MDS, this process is dysfunctional.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Azacitidine Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azacitidine Drug.
The Azacitidine Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Azacitidine Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Azacitidine Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Azacitidine Drug Market Report

Report Metric Details
Report Name Azacitidine Drug Market
Accounted market size in year US$ 94.8 million
Forecasted market size in 2031 US$ 119 million
CAGR 3.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Vidaza®
  • Generic Vidaza®
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Celgene, Mylan, Shilpa Medicare, Accord Healthcare, Natco Pharma, Dr. Reddy's Laboratories, MBA Pharmaceuticals Pvt Ltd, Taj Generics, Getwell Oncology, EVER Pharma, Xpreza, Shubham Pharmaceutical, Rizochem Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Azacitidine Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Azacitidine Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Azacitidine Drug Market growing?

Ans: The Azacitidine Drug Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Azacitidine Drug Market size in 2031?

Ans: The Azacitidine Drug Market size in 2031 will be US$ 119 million.

Who are the main players in the Azacitidine Drug Market report?

Ans: The main players in the Azacitidine Drug Market are Celgene, Mylan, Shilpa Medicare, Accord Healthcare, Natco Pharma, Dr. Reddy's Laboratories, MBA Pharmaceuticals Pvt Ltd, Taj Generics, Getwell Oncology, EVER Pharma, Xpreza, Shubham Pharmaceutical, Rizochem Pharmaceutical

What are the Application segmentation covered in the Azacitidine Drug Market report?

Ans: The Applications covered in the Azacitidine Drug Market report are Refractory anemia (RA), Refractory anemia with excess blasts (RAEB), Chronic myelomonocytic leukemia (CMMoL), Others

What are the Type segmentation covered in the Azacitidine Drug Market report?

Ans: The Types covered in the Azacitidine Drug Market report are Vidaza®, Generic Vidaza®

Recommended Reports

Pharmaceutical Drugs

Disease Therapy Markets

Neurology & Cardiovascular

1 Azacitidine Drug Market Overview
1.1 Product Definition
1.2 Azacitidine Drug by Type
1.2.1 Global Azacitidine Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vidaza®
1.2.3 Generic Vidaza®
1.3 Azacitidine Drug by Application
1.3.1 Global Azacitidine Drug Market Value by Application (2024 VS 2031)
1.3.2 Refractory anemia (RA)
1.3.3 Refractory anemia with excess blasts (RAEB)
1.3.4 Chronic myelomonocytic leukemia (CMMoL)
1.3.5 Others
1.4 Global Azacitidine Drug Market Size Estimates and Forecasts
1.4.1 Global Azacitidine Drug Revenue 2020-2031
1.4.2 Global Azacitidine Drug Sales 2020-2031
1.4.3 Global Azacitidine Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Azacitidine Drug Market Competition by Manufacturers
2.1 Global Azacitidine Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Azacitidine Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Azacitidine Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Azacitidine Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Azacitidine Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Azacitidine Drug, Product Type & Application
2.7 Global Key Manufacturers of Azacitidine Drug, Date of Enter into This Industry
2.8 Global Azacitidine Drug Market Competitive Situation and Trends
2.8.1 Global Azacitidine Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Azacitidine Drug Players Market Share by Revenue
2.8.3 Global Azacitidine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Azacitidine Drug Market Scenario by Region
3.1 Global Azacitidine Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Azacitidine Drug Sales by Region: 2020-2031
3.2.1 Global Azacitidine Drug Sales by Region: 2020-2025
3.2.2 Global Azacitidine Drug Sales by Region: 2026-2031
3.3 Global Azacitidine Drug Revenue by Region: 2020-2031
3.3.1 Global Azacitidine Drug Revenue by Region: 2020-2025
3.3.2 Global Azacitidine Drug Revenue by Region: 2026-2031
3.4 North America Azacitidine Drug Market Facts & Figures by Country
3.4.1 North America Azacitidine Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Azacitidine Drug Sales by Country (2020-2031)
3.4.3 North America Azacitidine Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Azacitidine Drug Market Facts & Figures by Country
3.5.1 Europe Azacitidine Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Azacitidine Drug Sales by Country (2020-2031)
3.5.3 Europe Azacitidine Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Azacitidine Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Azacitidine Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Azacitidine Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Azacitidine Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Azacitidine Drug Market Facts & Figures by Country
3.7.1 Latin America Azacitidine Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Azacitidine Drug Sales by Country (2020-2031)
3.7.3 Latin America Azacitidine Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Azacitidine Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Azacitidine Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Azacitidine Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Azacitidine Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Azacitidine Drug Sales by Type (2020-2031)
4.1.1 Global Azacitidine Drug Sales by Type (2020-2025)
4.1.2 Global Azacitidine Drug Sales by Type (2026-2031)
4.1.3 Global Azacitidine Drug Sales Market Share by Type (2020-2031)
4.2 Global Azacitidine Drug Revenue by Type (2020-2031)
4.2.1 Global Azacitidine Drug Revenue by Type (2020-2025)
4.2.2 Global Azacitidine Drug Revenue by Type (2026-2031)
4.2.3 Global Azacitidine Drug Revenue Market Share by Type (2020-2031)
4.3 Global Azacitidine Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Azacitidine Drug Sales by Application (2020-2031)
5.1.1 Global Azacitidine Drug Sales by Application (2020-2025)
5.1.2 Global Azacitidine Drug Sales by Application (2026-2031)
5.1.3 Global Azacitidine Drug Sales Market Share by Application (2020-2031)
5.2 Global Azacitidine Drug Revenue by Application (2020-2031)
5.2.1 Global Azacitidine Drug Revenue by Application (2020-2025)
5.2.2 Global Azacitidine Drug Revenue by Application (2026-2031)
5.2.3 Global Azacitidine Drug Revenue Market Share by Application (2020-2031)
5.3 Global Azacitidine Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Celgene
6.1.1 Celgene Company Information
6.1.2 Celgene Description and Business Overview
6.1.3 Celgene Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Celgene Azacitidine Drug Product Portfolio
6.1.5 Celgene Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Company Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan Azacitidine Drug Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Shilpa Medicare
6.3.1 Shilpa Medicare Company Information
6.3.2 Shilpa Medicare Description and Business Overview
6.3.3 Shilpa Medicare Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shilpa Medicare Azacitidine Drug Product Portfolio
6.3.5 Shilpa Medicare Recent Developments/Updates
6.4 Accord Healthcare
6.4.1 Accord Healthcare Company Information
6.4.2 Accord Healthcare Description and Business Overview
6.4.3 Accord Healthcare Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Accord Healthcare Azacitidine Drug Product Portfolio
6.4.5 Accord Healthcare Recent Developments/Updates
6.5 Natco Pharma
6.5.1 Natco Pharma Company Information
6.5.2 Natco Pharma Description and Business Overview
6.5.3 Natco Pharma Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Natco Pharma Azacitidine Drug Product Portfolio
6.5.5 Natco Pharma Recent Developments/Updates
6.6 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Company Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dr. Reddy's Laboratories Azacitidine Drug Product Portfolio
6.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.7 MBA Pharmaceuticals Pvt Ltd
6.7.1 MBA Pharmaceuticals Pvt Ltd Company Information
6.7.2 MBA Pharmaceuticals Pvt Ltd Description and Business Overview
6.7.3 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolio
6.7.5 MBA Pharmaceuticals Pvt Ltd Recent Developments/Updates
6.8 Taj Generics
6.8.1 Taj Generics Company Information
6.8.2 Taj Generics Description and Business Overview
6.8.3 Taj Generics Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Taj Generics Azacitidine Drug Product Portfolio
6.8.5 Taj Generics Recent Developments/Updates
6.9 Getwell Oncology
6.9.1 Getwell Oncology Company Information
6.9.2 Getwell Oncology Description and Business Overview
6.9.3 Getwell Oncology Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Getwell Oncology Azacitidine Drug Product Portfolio
6.9.5 Getwell Oncology Recent Developments/Updates
6.10 EVER Pharma
6.10.1 EVER Pharma Company Information
6.10.2 EVER Pharma Description and Business Overview
6.10.3 EVER Pharma Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 EVER Pharma Azacitidine Drug Product Portfolio
6.10.5 EVER Pharma Recent Developments/Updates
6.11 Xpreza
6.11.1 Xpreza Company Information
6.11.2 Xpreza Description and Business Overview
6.11.3 Xpreza Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Xpreza Azacitidine Drug Product Portfolio
6.11.5 Xpreza Recent Developments/Updates
6.12 Shubham Pharmaceutical
6.12.1 Shubham Pharmaceutical Company Information
6.12.2 Shubham Pharmaceutical Description and Business Overview
6.12.3 Shubham Pharmaceutical Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shubham Pharmaceutical Azacitidine Drug Product Portfolio
6.12.5 Shubham Pharmaceutical Recent Developments/Updates
6.13 Rizochem Pharmaceutical
6.13.1 Rizochem Pharmaceutical Company Information
6.13.2 Rizochem Pharmaceutical Description and Business Overview
6.13.3 Rizochem Pharmaceutical Azacitidine Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Rizochem Pharmaceutical Azacitidine Drug Product Portfolio
6.13.5 Rizochem Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Azacitidine Drug Industry Chain Analysis
7.2 Azacitidine Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Azacitidine Drug Production Mode & Process Analysis
7.4 Azacitidine Drug Sales and Marketing
7.4.1 Azacitidine Drug Sales Channels
7.4.2 Azacitidine Drug Distributors
7.5 Azacitidine Drug Customer Analysis
8 Azacitidine Drug Market Dynamics
8.1 Azacitidine Drug Industry Trends
8.2 Azacitidine Drug Market Drivers
8.3 Azacitidine Drug Market Challenges
8.4 Azacitidine Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Azacitidine Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Azacitidine Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Azacitidine Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Azacitidine Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Azacitidine Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Azacitidine Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Azacitidine Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Azacitidine Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Azacitidine Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Azacitidine Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Azacitidine Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Azacitidine Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Azacitidine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Azacitidine Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Azacitidine Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Azacitidine Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Azacitidine Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Azacitidine Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Azacitidine Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Azacitidine Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Azacitidine Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Azacitidine Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Azacitidine Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Azacitidine Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Azacitidine Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Azacitidine Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Azacitidine Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Azacitidine Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Azacitidine Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Azacitidine Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Azacitidine Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Azacitidine Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Azacitidine Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Azacitidine Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Azacitidine Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Azacitidine Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Azacitidine Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Azacitidine Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Azacitidine Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Azacitidine Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Azacitidine Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Azacitidine Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Azacitidine Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Azacitidine Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Azacitidine Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Azacitidine Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Azacitidine Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Azacitidine Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Azacitidine Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Azacitidine Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Azacitidine Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Azacitidine Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Azacitidine Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Azacitidine Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Azacitidine Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Azacitidine Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Azacitidine Drug Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Azacitidine Drug Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Azacitidine Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Azacitidine Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Azacitidine Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Azacitidine Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Azacitidine Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Azacitidine Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Azacitidine Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Azacitidine Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Azacitidine Drug Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Azacitidine Drug Price (USD/Unit) by Application (2026-2031)
 Table 70. Celgene Company Information
 Table 71. Celgene Description and Business Overview
 Table 72. Celgene Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Celgene Azacitidine Drug Product
 Table 74. Celgene Recent Developments/Updates
 Table 75. Mylan Company Information
 Table 76. Mylan Description and Business Overview
 Table 77. Mylan Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Mylan Azacitidine Drug Product
 Table 79. Mylan Recent Developments/Updates
 Table 80. Shilpa Medicare Company Information
 Table 81. Shilpa Medicare Description and Business Overview
 Table 82. Shilpa Medicare Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Shilpa Medicare Azacitidine Drug Product
 Table 84. Shilpa Medicare Recent Developments/Updates
 Table 85. Accord Healthcare Company Information
 Table 86. Accord Healthcare Description and Business Overview
 Table 87. Accord Healthcare Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Accord Healthcare Azacitidine Drug Product
 Table 89. Accord Healthcare Recent Developments/Updates
 Table 90. Natco Pharma Company Information
 Table 91. Natco Pharma Description and Business Overview
 Table 92. Natco Pharma Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Natco Pharma Azacitidine Drug Product
 Table 94. Natco Pharma Recent Developments/Updates
 Table 95. Dr. Reddy's Laboratories Company Information
 Table 96. Dr. Reddy's Laboratories Description and Business Overview
 Table 97. Dr. Reddy's Laboratories Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Dr. Reddy's Laboratories Azacitidine Drug Product
 Table 99. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 100. MBA Pharmaceuticals Pvt Ltd Company Information
 Table 101. MBA Pharmaceuticals Pvt Ltd Description and Business Overview
 Table 102. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product
 Table 104. MBA Pharmaceuticals Pvt Ltd Recent Developments/Updates
 Table 105. Taj Generics Company Information
 Table 106. Taj Generics Description and Business Overview
 Table 107. Taj Generics Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Taj Generics Azacitidine Drug Product
 Table 109. Taj Generics Recent Developments/Updates
 Table 110. Getwell Oncology Company Information
 Table 111. Getwell Oncology Description and Business Overview
 Table 112. Getwell Oncology Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Getwell Oncology Azacitidine Drug Product
 Table 114. Getwell Oncology Recent Developments/Updates
 Table 115. EVER Pharma Company Information
 Table 116. EVER Pharma Description and Business Overview
 Table 117. EVER Pharma Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. EVER Pharma Azacitidine Drug Product
 Table 119. EVER Pharma Recent Developments/Updates
 Table 120. Xpreza Company Information
 Table 121. Xpreza Description and Business Overview
 Table 122. Xpreza Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Xpreza Azacitidine Drug Product
 Table 124. Xpreza Recent Developments/Updates
 Table 125. Shubham Pharmaceutical Company Information
 Table 126. Shubham Pharmaceutical Description and Business Overview
 Table 127. Shubham Pharmaceutical Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Shubham Pharmaceutical Azacitidine Drug Product
 Table 129. Shubham Pharmaceutical Recent Developments/Updates
 Table 130. Rizochem Pharmaceutical Company Information
 Table 131. Rizochem Pharmaceutical Description and Business Overview
 Table 132. Rizochem Pharmaceutical Azacitidine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Rizochem Pharmaceutical Azacitidine Drug Product
 Table 134. Rizochem Pharmaceutical Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Azacitidine Drug Distributors List
 Table 138. Azacitidine Drug Customers List
 Table 139. Azacitidine Drug Market Trends
 Table 140. Azacitidine Drug Market Drivers
 Table 141. Azacitidine Drug Market Challenges
 Table 142. Azacitidine Drug Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Azacitidine Drug
 Figure 2. Global Azacitidine Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Azacitidine Drug Market Share by Type: 2024 & 2031
 Figure 4. Vidaza® Product Picture
 Figure 5. Generic Vidaza® Product Picture
 Figure 6. Global Azacitidine Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Azacitidine Drug Market Share by Application: 2024 & 2031
 Figure 8. Refractory anemia (RA)
 Figure 9. Refractory anemia with excess blasts (RAEB)
 Figure 10. Chronic myelomonocytic leukemia (CMMoL)
 Figure 11. Others
 Figure 12. Global Azacitidine Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Azacitidine Drug Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Azacitidine Drug Sales (2020-2031) & (K Units)
 Figure 15. Global Azacitidine Drug Average Price (USD/Unit) & (2020-2031)
 Figure 16. Azacitidine Drug Report Years Considered
 Figure 17. Azacitidine Drug Sales Share by Manufacturers in 2024
 Figure 18. Global Azacitidine Drug Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Azacitidine Drug Players: Market Share by Revenue in Azacitidine Drug in 2024
 Figure 20. Azacitidine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Azacitidine Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Azacitidine Drug Sales Market Share by Country (2020-2031)
 Figure 23. North America Azacitidine Drug Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Azacitidine Drug Sales Market Share by Country (2020-2031)
 Figure 27. Europe Azacitidine Drug Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Azacitidine Drug Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Azacitidine Drug Revenue Market Share by Region (2020-2031)
 Figure 35. China Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Azacitidine Drug Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Azacitidine Drug Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Azacitidine Drug Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Azacitidine Drug Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Azacitidine Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Azacitidine Drug by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Azacitidine Drug by Type (2020-2031)
 Figure 57. Global Azacitidine Drug Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Azacitidine Drug by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Azacitidine Drug by Application (2020-2031)
 Figure 60. Global Azacitidine Drug Price (USD/Unit) by Application (2020-2031)
 Figure 61. Azacitidine Drug Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart